New Diabetes Drug May Offer Advantages
LIRAGLUTIDE, a human glucagonlike peptide 1 (GLP-1) analog, is safe and effective as once-daily initial pharmacologic therapy for treating type 2 diabetes, data suggest.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.